Perimenopause

"Perimenopause" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The transitional period before and after MENOPAUSE. Perimenopausal symptoms are associated with irregular MENSTRUAL CYCLE and widely fluctuated hormone levels. They may appear 6 years before menopause and subside 2 to 5 years after menopause.

Descriptor ID	D047648
MeSH Number(s)	G08.686.157.500.562 G08.686.841.249.500.562
Concept/Terms	Perimenopause Perimenopause

Below are MeSH descriptors whose meaning is more general than "Perimenopause".

Biological Sciences [G]
Reproductive and Urinary Physiological Phenomena [G08]
Reproductive Physiological Phenomena [G08.686]
Climacteric [G08.686.157]
Menopause [G08.686.157.500]
Perimenopause [G08.686.157.500.562]
Sexual Development [G08.686.841]
Climacteric [G08.686.841.249]
Menopause [G08.686.841.249.500]
Perimenopause [G08.686.841.249.500.562]

Below are MeSH descriptors whose meaning is related to "Perimenopause".

Below are MeSH descriptors whose meaning is more specific than "Perimenopause".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Perimenopause" by people in this website by year, and whether "Perimenopause" was a major or minor topic of these publications.

Bar chart showing 4 publications over 4 distinct years, with a maximum of 1 publications in 2005 and 2012 and 2017 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	1	0	1
2012	0	1	1
2017	1	0	1
2019	1	0	1

Below are the most recent publications written about "Perimenopause" by people in Profiles.

Schneider LS, Hernandez G, Zhao L, Franke AA, Chen YL, Pawluczyk S, Mack WJ, Brinton RD. Safety and feasibility of estrogen receptor-? targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial. Menopause. 2019 08; 26(8):874-884.

View in: PubMed
Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, L?pez-Ridaura R, Rice M, Pereira A, Garmendia ML, Tamimi RM, Bertrand K, Kwong A, Ursin G, Lee E, Qureshi SA, Ma H, Vinnicombe S, Moss S, Allen S, Ndumia R, Vinayak S, Teo SH, Mariapun S, Fadzli F, Peplonska B, Bukowska A, Nagata C, Stone J, Hopper J, Giles G, Ozmen V, Aribal ME, Sch?z J, Van Gils CH, Wanders JOP, Sirous R, Sirous M, Hipwell J, Kim J, Lee JW, Dickens C, Hartman M, Chia KS, Scott C, Chiarelli AM, Linton L, Pollan M, Flugelman AA, Salem D, Kamal R, Boyd N, Dos-Santos-Silva I, McCormack V. Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide. PLoS Med. 2017 Jun; 14(6):e1002335.

View in: PubMed
Bowman E, Oprea G, Okoli J, Gundry K, Rizzo M, Gabram-Mendola S, Manne U, Smith G, Pambuccian S, Bumpers HL. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Breast J. 2012 May-Jun; 18(3):242-7.

View in: PubMed
Ferrell RJ, Simon JA, Pincus SM, Rodr?guez G, O'Connor KA, Holman DJ, Weinstein M. The length of perimenopausal menstrual cycles increases later and to a greater degree than previously reported. Fertil Steril. 2006 Sep; 86(3):619-24.

View in: PubMed
Suau GM, Normandia R, Rodriguez R, Romaguera J, Segarra L. Depressive symptoms and risk factors among perimenopausal women. P R Health Sci J. 2005 Sep; 24(3):207-10.

View in: PubMed

People

Explore

Similar Concepts

Top Journals